108999 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes Enzyme inactivation by chemical treatment
COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF
#2CYCLIN-DEPENDENT KINASE 7 INHIBITORS
#3Biosensor and Assays for Rapid Detection of Antibiotic Resistance
#4NOVEL ANTI-PAD4 ANTIBODY
#5ANTI-CRISPR DELIVERY COMPOSITIONS AND METHODS
#6Urease inhibiting composition and use of same
#7COMPOSITIONS FOR OVERCOMING TETRACYCLINE ANTIBIOTIC RESISTANCE AND METHODS OF USE THEREOF
#8CRYSTALLINE FORMS OF A GLUCOSYLCERAMIDE SYNTHASE INHIBITOR AND USES THEREOF
#9Prostaglandin E synthase 3 (PTGES3) Inhibiting Compounds
#10TREATMENT OF CANCER USING ORGANOARSENICALS
#11PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
#12Methods for Targeting Cancer Cells Using Amino Acids
#13Heparanase Inhibition for Graft Protection
#14INHIBITION OF DNA POLYMERASES BY URACIL-DNA GLYCOSYLASE-CLEAVABLE OLIGONUCLEOTIDE LIGANDS
#15ANTI-CD38 ANTIBODIES
#16MOLIDUSTAT FORMULATIONS AND METHODS OF USE FOR TREATMENT OF ANEMIA IN CATS
#17THERAPEUTIC COMPOUNDS
#18SELECTION INHIBITION OF DNA POLYMERASE BETA BY A COVALENT INHIBITOR
#19RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN
#20Tricyclic Derivatives Useful As PARP7 Inhibitors
#21COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS
#22COVALENT AND NON-COVALENT INHIBITORS OF CORONAVIRUS PAPAIN-LIKE PROTEASE
#23TETRAZOLIUM-BASED COLORIMETRIC ASSAY
#24NOVEL REDOX-BASED THERAPEUTIC APPROACH FOR TREATMENT OF CANCER
#257-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor
#26ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE
#27COMPOUNDS HAVING SELECTIVE INACTIVATION ACTIVITY
#28COMBINATION DRUG FOR TREATING RENAL CANCER AND POTENTIATOR FOR THERAPEUTIC EFFECTS OF TYROSINE KINASE INHIBITOR
#29THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER
#30COMPOSITIONS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN AND METHODS THEREOF
#31Preservation of cell-free nucleic acids in biological samples
#32NUCLEIC ACID LIGAND AND USE THEREOF
#33NOVEL ANTI-PAD4 ANTIBODY
#34Anti-CD38 antibodies
#35Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
#36INHIBITORS OF SARM1
#37COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS
#38Heteroaryl modulators of RAS GTPase
#39Small Molecule Modulators of RAS GTPase
#40Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
#41Chymotrypsin Inhibitor Variants And The Use Thereof
#42INHIBITORS OF ENZYMES THAT CONFER PESTICIDE RESISTANCE
#43Method for introducing molecule and composition containing inhibitor
#44INHIBITORS OF RNA-GUIDED NUCLEASE TARGET BINDING AND USES THEREOF
#45Linear glycosidase inhibitors
#46Simplified Process For Producing Maltodextrin and Specialty Syrups
#47Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
#48Preservation of cell-free nucleic acids in biological samples
#49Compositions relating to a mutant clostridium difficile toxin and methods thereof
#50TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#51Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody
#52Inhibitors of human phosphatidylinositol 3-kinase delta
#53Anti-CD38 antibodies
#54CONJUGATED ANTI-CD38 ANTIBODIES
#55Bioluminescent assays utilising secreted luciferases
#56Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis
#57Catalase inhibitor and method for measuring analyte using catalase inhibitor
#58Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders
#59Antidote for Chondroitinase
#60Heterocyclic amide compound
#61Method and apparatus for controlled hydrolysis
#62Compositions relating to a mutant clostridium difficile toxin and methods thereof
#63MK2 inhibitors and uses thereof
#64Methods and compounds for reducing threonyl-tRNA synthetase activity
#65Blood collection tube, reagent, and method for analyzing blood characteristics using same
#66Antibodies for detecting redox modulated proteins
#67Inhibitors of human phosphatidylinositol 3-kinase delta
#68INACTIVATION OF PROTEASES
#69Derivatized 3-styryl-cephalosporins
#70POTENT NON-UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
#71Oligonucleotide inhibitor of DNA polymerases
#72Inhibitors of enzymes that confer pesticide resistance
#73Heterocyclic compound
#74Monocyclic compound
#75Anti-CD38 antibodies
#76Tetrahydrothiophene-based GABA aminotransferase inactivators
#77Anti-PAD4 antibody
#78Conjugated anti-CD38 antibodies
#79Inhibition and diagnostics of emerging tetracycline resistance enzymes
#80Inhibitors of human phosphatidylinositol 3-kinase delta
#81Compositions relating to a mutant toxin and methods thereof
#82INDOLE DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS
#83Inactivation of off-taste inducing enzymes
#84Bioluminescent assays utilising secreted luciferases
#85Heterocyclic compounds having cholesterol 24-hydroxylase activity
#86Inactivation Method
#87INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#88Neurodegenerative therapies
#89Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production
#90HCV PROTEASE INHIBITORS AND USES THEREOF
#91Purification of cell culture derived alpha1 protease inhibitor
#92Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
#93Tetrahydrothiophene-based GABA aminotransferase inactivators
#94Small molecule securinine and norsecurinine analogs and their use in inhibiting myeloperoxidase
#95Small molecule securinine and norsecurinine analogs and their use in cancers, inflammatory diseases and infections
#96Compositions and methods for the identification of inhibitors of retroviral infection
#97Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#98Methods of modulating ubiquitin ligase activity
#99Methods and compositions for selective and targeted cancer therapy
#100Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines
#101Pyrazolo compounds and uses thereof
#102Potent non-urea inhibitors of soluble epoxide hydrolase
#103Derivatized 3-styryl-cephalosporins
#104HETEROARYL COMPOUNDS AND USES THEREOF
#105Method for modulating a bacterial invasion switch
#106MK2 inhibitors and uses thereof
#107Baulamycins, compositions and methods of use thereof
#108Heterocyclic compounds having cholesterol 24-hydroxylase activity
#109Conjugated anti-CD38 antibodies
#110Compositions and methods for redox modulated proteins
#111Glycosidase inhibitors and uses thereof
#112Intramolecular hydrogen-bonded nitric oxide synthase inhibitors
#113NOVEL RAF KINASE INHIBITORS
#114Methods of modulating ubiquitin ligase activity
#115Methods and compounds for reducing threonyl-tRNA synthetase activity
#116Anti-CD38 antibodies
#117Bioluminescent assays utilising secreted luciferases
#118Heavy metal stabilization and methane inhibition during induced or naturally occurring reducing conditions in contaminated media
#119Oligonucleotide inhibitor of DNA polymerases
#120HCV protease inhibitors and uses thereof
#121Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
#122Soft protease inhibitors and pro-soft forms thereof
#123Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
#124Boronic and borinic acid compound as inhibitors of sulfenic acid-containing proteins
#125Compositions relating to a mutant toxin and methods thereof
#126Method for preserving components of pancreatic juice in a sample, and kit for preserving components of pancreatic juice in a sample
#127Method of inhibiting C-KIT kinase
#128MONOMERS CAPABLE OF MULTIMERIZING IN AN AQUEOUS SOLUTION THAT EMPLOY BIOORTHOGONAL CHEMISTRIES, AND METHODS OF USING SAME
#129Method of enzyme inactivation
#130CRYSTAL STRUCTURE OF A TYPE IB P-TYPE ATPase
#131HCV PROTEASE INHIBITORS AND USES THEREOF
#132Cyclic molecules as bruton's tyrosine kinase inhibitors
#133Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#134PKC-epsilon inhibitors
#135Inhibitors of c-fms kinase
#136Identification and molecular characterisation of proteins, expressed in the salivary glands
#137Potent non-urea inhibitors of soluble epdxide hydrolase
#138Inhibitors of c-fms kinase
#139Arginine methyltransferase inhibitors and uses thereof
#140DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS
#141Inhibitors of extracellular proteases
#142Inhibitors of C-FMS kinase
#143PEPTIDE FOR INHIBITING DIPEPTIDYL-PEPTIDASE IV
#144Aryl ether-base kinase inhibitors
#145Verticillin A Inhibition of Histone Methyltransferases
#146Conjugated anti-CD38 antibodies
#147Inhibitors of human phosphatidylinositol 3-kinase delta
#148Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
#149Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production
#150Soft protease inhibitors and pro-soft forms thereof
#151Hepsin inhibitors
#152Compositions and methods for the identification of inhibitors of retroviral infection
#153Protein removal agent
#154Selective glycosidase inhibitors and uses thereof
#155Aminopyrimidine kinase inhibitors
#156METHODS FOR REACTING CYSTEINE RESIDUES IN PEPTIDES AND PROTEINS
#157Purification of cell culture derived alphaprotease inhibitor
#158Nuclease Reduction
#159Method for modulating a bacterial invasion switch
#160Method of inhibiting C-KIT kinase
#161Thioxothiazolidine inhibitors
#162Nuclease inhibitors and methods for their use
#163Compositions relating to a mutant toxin and methods thereof
#164INHIBITORS OF EXTRACELLULAR PROTEASES
#165THIOPHENE-CARBOXAMIDES USEFUL AS INHIBITORS OF PROTEIN KINASES
#166Medicament for LCT poisoning
#167Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus
#168Antibacterial agents: high-potency myxopyronin derivatives
#169Aryl ether-base kinase inhibitors
#170ENDOTHELIAL NITRIC OXIDE SYNTHASE
#171Method for inhibiting the formation of SET1 family core complexes
#172Inhibitors of Serine Proteases
#173Anti-CD38 antibodies
#174Quinazoline compounds as kinase inhibitors
#175PROCESS FOR THE PRODUCTION OF A REVERSIBLY INACTIVE ACIDIFIED PLASMIN COMPOSITION
#176CONTROL OF ENZYMES IN THE PRODUCTION OF PULP
#177Reversibly inactivated acidified plasmin composition
#178Pyrazoloquinolines
#179Soft protease inhibitors and pro-soft forms thereof
#180Identification and molecular characterisation of proteins, expressed in the salivary glands
#181HCV protease inhibitors and uses thereof
#182Inactivation of Proteases
#183Compositions relating to a mutant toxin and methods thereof
#184AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT PEPTIDYL-DIPEPTIDASE A ACTIVITY
#185Ribonucleotide reductase inhibitors and methods of use
#186INACTIVATION OF OFF-TASTE INDUCING ENZYMES
#187Anti-CD38 antibodies
#188HCV protease inhibitors and uses thereof
#189Inhibitors of human phosphatidylinositol 3-kinase delta
#190Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)
#191Thiophene-carboxamides useful as inhibitors of protein kinases
#192USP47 inhibitors and methods to induce apoptosis
#193ANTIVIRAL THERAPEUTIC AGENTS
#194Inhibitors of human phosphatidylinositol 3-kinase delta
#195Metalloprotein inhibitors containing nitrogen based ligands
#196NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#197Intramolecular hydrogen-bonded nitric oxide synthase inhibitors
#198Deubiquitinase inhibitors and methods for use of the same
#199Hydrobromide salts of a pyrazolylaminoquinazoline
#200Potent non-urea inhibitors of soluble epoxide hydrolase
#201Process and microorganisms for production of lipids from lignocellulosic wastes or residues
#202Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
#203Jasmonic acid compounds in cocoa products
#204Ribonucleotide reductase inhibitors and methods of use
#205Method of treating inflammation with statins
#206Compositions and methods for redox modulated proteins
#207Nuclease reduction
#208INHIBITORS OF EXTRACELLULAR PROTEASES
#209Method for producing sugar
#210Thiophene-carboxamides useful as inhibitors of protein kinases
#211membrane protease as a target for inhibitors of intrabacterial pH homeostasis
#212INHIBITORS OF SERINE PROTEASES
#213TREATMENT AND REUSE OF OILFIELD PRODUCED WATER
#214Aminopyrimidine kinase inhibitors
#215POLYPHENOL COMPOUNDS FOR INHIBITING PROTEASOME AND USES THEREOF
#216Hepsin inhibitors
#217Method of producing tibolone metabolites by fermentation with
#218Method of producing tibolone metabolites by fermentation with
#219Method of producing tibolone metabolites by fermentation with
#220Method of producing tibolone metabolites by fermentation with
#221THERAPEUTIC ANTIVIRAL PEPTIDES
#222Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
#223SELECTIVE PROTON COUPLED FOLATE TRANSPORTER AND FOLATE RECEPTOR, AND GARFTASE AND/OR OTHER FOLATE METABOLIZING ENZYMES INHIBITOR COMPOUNDS AND METHODS OF USING THE SAME
#224c-MET protein kinase inhibitors
#225BATE-LACTAMASE INHIBITORS
#226COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#227METHOD FOR INHIBITING BRASSININ OXIDASE
#228COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#229Method for inhibiting telomerase reaction using an anionic phthalocyanine compound
#230β-glucuronidase inhibitor
#231TARGETED BINDING AGENTS DIRECTED TO HEPARANASE AND USES THEREOF 463
#232Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#233Methods and Compositions for PDGF-C Activation and Inhibition
#234Inhibitors of human phosphatidylinositol 3-kinase delta
#235Inhibitors of human phosphatidylinositol 3-kinase delta
#236Bioluminescent assays utilising secreted luciferases
#237Fused multicyclic compounds as protein kinase inhibitors
#238HCV protease inhibitors and uses thereof
#239HCV protease inhibitors and uses thereof
#240Protein kinase C zeta inhibition to treat diabetic retinopathy
#241MEDICAMENT FOR LCT POISONING
#242Phosphatases involved in the regulation of cardiomyocyte differentiation
#243USP47 inhibtors and methods to induce apoptosis
#244Ribonucleotide reductase inhibitors and methods of use
#245Antiviral therapeutic agents
#246INHIBITORS OF NITRIC OXIDE SYNTHASE
#247Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones
#248Soft protease inhibitors and pro-soft forms thereof
#249Renin inhibitors
#250Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
#251Sir2 products and activities
#252Plant extracts and compositions comprising extracellular protease inhibitors
#253Methods and compositions for PDGF-C activation and inhibition
#254BROMELAIN AS A CLINICAL SAMPLE PRE-TREATMENT, LYSIS AGENT AND NUCLEASE INHIBITOR
#255α-glucosidase inhibitors from lichens
#256Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
#257Reversibly inactivated acidified plasmin
#258Antibacterial agents
#259Treatment and Reuse of Oilfield Produced Water
#260METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#261Stabilization of biological materials through inactivation of metalloenzymes
#262Identification and molecular characterisation of proteins, expressed in the salivary glands
#263MYCOBACTERIAL SULFATION PATHWAY PROTEINS AND METHODS OF USE THEREOF
#264Novel Pd Marker for Histone Deacetylase Inhibitor
#265Thiophene-carboxamides useful as inhibitors of protein kinases
#266Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase
#267Method of inhibiting C-KIT kinase
#268Protein kinase C zeta inhibition to treat vascular permeability
#269Enhancing reactivation of thermostable reversibly inactivated enzymes
#270c-MET protein kinase inhibitors
#271Aminoquinolones as GSK-3 inhibitors
#272Inhibitors of C-FMS kinase
#273Inhibitors of c-fms kinase
#274Inhibitors of c-fms kinase
#275Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
#276Inactivation method
#277Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
#278Methods for production of recombinant alpha1-antitrypsin
#279Purification methods and uses thereof
#280Rationally designed heparinases derived from heparinase II
#281Cyclic onium compounds and glucosidase inhibitors
#282Compositions and methods for increasing amplification efficiency
#283Inhibitors of serine proteases
#284Sulfotransferase inhibitor
#285Inhibitors of nitric oxide synthase to treat type 1 diabetes
#286Methods of using a DNase I-like enzyme
#287Mycobacterial sulfation pathway proteins and methods of use thereof
#288Process for inhibiting enzymatic activity
#289Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
#290Methods and compositions for PDGF-C activation and inhibition
#291Compositions and methods for inhibiting mucin-type O-linked glycosylation
#292Sir2 products and activities
#293Anticancer agents based on prevention of protein prenylation
#294Reversibly modified thermostable enzyme compositions and methods of making and using the same
#295Methods and materials for enhancing the effects of protein modulators
#296Inhibitors of human phosphatidylinositol 3-kinase delta
#297Nuclease inhibitors and methods for their use
#298Formulations and methods for denaturing proteins
#299Method for the inactivation of amylase in the presence of protease
#300Method of treating middle east respiratory syndrome (MERS)